Takeda, Arch back hC Bioscience with $24M for transfer RNAs, following Flagship into the field
Takeda, Arch back hC Bioscience with $24M for transfer RNAs, [...]
Orphazyme goes soul searching as EU advisers add 2nd rejection for rare disease drug
Orphazyme goes soul searching as EU advisers add 2nd rejection [...]
Merck cuts ties to Moderna’s early-phase KRAS vaccine, leaving mRNA specialist to mull next steps
Merck cuts ties to Moderna’s early-phase KRAS vaccine, leaving mRNA [...]
Amicus’ gene therapy SPAC merger folds, turning pipeline and R&D into target of $400M in cuts
Amicus’ gene therapy SPAC merger folds, turning pipeline and R&D [...]
Mnemo lures Bayer oncology business chief as new CEO to lead CAR-T work
Mnemo lures Bayer oncology business chief as new CEO to [...]
Kodiak’s Eylea rival hits ‘major disappointment’ with failure in first of 6 phase 3 studies
Kodiak’s Eylea rival hits ‘major disappointment’ with failure in first [...]
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators
Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, [...]
Stability woes torpedo Marinus’ phase 3 seizure timeline, combining with COVID-19 to cause one-year delay
Stability woes torpedo Marinus’ phase 3 seizure timeline, combining with [...]
Adagio CEO resigns with no explanation and the biotech plans COVID-19 antibody analysis this quarter
Adagio CEO resigns with no explanation and the biotech plans [...]
Building off Prevail buy, Lilly to construct $700 million Boston research hub in gene therapy blitz
Building off Prevail buy, Lilly to construct $700 million Boston [...]